BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37310496)

  • 41. Association between systemic inflammation biomarkers and mortality in patients with sepsis-associated acute kidney injury receiving intensive care and continuous kidney replacement therapy: results from the RENERGY (REsearches for NEphRology and epidemioloGY) study.
    Jung CY; Jung J; Lim JH; Paek JH; Kim K; Ban TH; Park JY; Kim H; Kim YC; Baek CH
    Kidney Res Clin Pract; 2024 Jun; ():. PubMed ID: 38934032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Using Blood Warmer During Continuous Kidney Replacement Therapy in Patients With Acute Kidney Injury.
    Doddi A; Abbasi A; Ramesh A; Moursy S; Sakhuja A; Shawwa K
    J Intensive Care Med; 2024 Apr; 39(4):387-394. PubMed ID: 37885206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kidney replacement therapy in neonates: utilization trends and outcomes.
    Elgendy MM; Othman HF; Mohamed MA; Matar RB; Aly H
    Pediatr Nephrol; 2023 Mar; 38(3):867-876. PubMed ID: 35790647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superiority of Simplified Acute Physiologic Score II Compared with Acute Physiologic and Chronic Health Evaluation II and Sequential Organ Failure Assessment Scores for Predicting 48-Hour Mortality in Patients Receiving Continuous Kidney Replacement Therapy.
    Jung HY; Jeon Y; Jeon S; Lim JH; Kim YL
    Nephron; 2022; 146(4):369-376. PubMed ID: 35100603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Euglycemic Ketosis During Continuous Kidney Replacement Therapy With Glucose-Free Solution: A Report of 8 Cases.
    Ting S; Chua HR; Cove ME
    Am J Kidney Dis; 2021 Aug; 78(2):305-308. PubMed ID: 33278477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies.
    Anderson A; Shoulders L; James V; Ashcraft E; Cheng C; Ribeiro R; Elbahlawan L
    Front Oncol; 2023; 13():1234677. PubMed ID: 37664024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy.
    Selewski DT; Cornell TT; Blatt NB; Han YY; Mottes T; Kommareddi M; Gaies MG; Annich GM; Kershaw DB; Shanley TP; Heung M
    Crit Care Med; 2012 Sep; 40(9):2694-9. PubMed ID: 22743776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timing of continuous renal replacement therapy and mortality in critically ill children*.
    Modem V; Thompson M; Gollhofer D; Dhar AV; Quigley R
    Crit Care Med; 2014 Apr; 42(4):943-53. PubMed ID: 24231758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic Plasma Exchange Is Associated With Improved Major Adverse Kidney Events in Children and Young Adults With Thrombocytopenia at the Time of Continuous Kidney Replacement Therapy Initiation.
    Fuhrman DY; Thadani S; Hanson C; Carcillo JA; Kellum JA; Park HJ; Lu L; Kim-Campbell N; Horvat CM; Arikan AA
    Crit Care Explor; 2023 Apr; 5(4):e0891. PubMed ID: 37066071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
    Kameda S; Fujii T; Ikeda J; Kageyama A; Takagi T; Miyayama N; Asano K; Endo A; Uezono S
    BMC Nephrol; 2023 Jan; 24(1):12. PubMed ID: 36642717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of continuous venovenous hemodiafiltration on amino acid delivery, clearance, and removal in children.
    Lion RP; Vega MR; Smith EO; Devaraj S; Braun MC; Bryan NS; Desai MS; Coss-Bu JA; Ikizler TA; Akcan Arikan A
    Pediatr Nephrol; 2022 Feb; 37(2):433-441. PubMed ID: 34386851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study.
    Gorga SM; Sahay RD; Askenazi DJ; Bridges BC; Cooper DS; Paden ML; Zappitelli M; Gist KM; Gien J; Basu RK; Jetton JG; Murphy HJ; King E; Fleming GM; Selewski DT
    Pediatr Nephrol; 2020 May; 35(5):871-882. PubMed ID: 31953749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Meta-Analysis of Extracorporeal Anticoagulants in Pediatric Continuous Kidney Replacement Therapy.
    Raina R; Agrawal N; Kusumi K; Pandey A; Tibrewal A; Botsch A
    J Intensive Care Med; 2022 May; 37(5):577-594. PubMed ID: 33688766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Innovative Approach to Minimizing Downtime in Continuous Kidney Replacement Therapy.
    Treu D; Ashenuga M; Massingham K; Brugger J; Medina L; Ficociello LH; Thompson D
    ASAIO J; 2023 Jun; 69(6):e250-e255. PubMed ID: 36976305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluid Overload Associates With Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
    Woodward CW; Lambert J; Ortiz-Soriano V; Li Y; Ruiz-Conejo M; Bissell BD; Kelly A; Adams P; Yessayan L; Morris PE; Neyra JA
    Crit Care Med; 2019 Sep; 47(9):e753-e760. PubMed ID: 31162196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dialysis disequilibrium on CKRT: avoiding the steep slippery slope.
    Stahl JL; Whelan RS; Symons JM
    Pediatr Nephrol; 2021 Sep; 36(9):2697-2702. PubMed ID: 33835264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.
    Selig DJ; DeLuca JP; Chung KK; Pruskowski KA; Livezey JR; Nadeau RJ; Por ED; Akers KS
    J Clin Pharm Ther; 2022 Aug; 47(8):1091-1102. PubMed ID: 35352374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Case Series: Continuous Kidney Replacement Therapy in Neonates With Low Body Weight.
    Wu CY; Lin YC; Chen CC
    Front Pediatr; 2021; 9():769220. PubMed ID: 34869123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy.
    Butragueño-Laiseca L; Marco-Ariño N; Troconiz IF; Grau S; Campillo N; García X; Padilla B; Fernández SN; Slöcker M; Santiago MJ
    Clin Microbiol Infect; 2022 Sep; 28(9):1287.e9-1287.e15. PubMed ID: 35390523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.
    Raina R; Chakraborty R; Davenport A; Brophy P; Sethi S; McCulloch M; Bunchman T; Yap HK
    Pediatr Nephrol; 2022 Oct; 37(10):2303-2330. PubMed ID: 34668064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.